$KBH
KB HOME Stock $kbh

$kbh Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000079526614000025 Filed on April 07, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$450.7M	$405.2M
YoY Change	11.22%	59.19%
Cost Of Revenue	$369.3M	$343.3M
YoY Change	7.57%	48.1%
Gross Profit	$80.56M	$61.12M
YoY Change	31.81%	179.2%
Gross Profit Margin	17.88%	15.08%
Selling, General & Admin	$61.27M	$59.10M
YoY Change	3.68%	15.4%
% of Gross Profit	76.06%	96.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$500.0K	$500.0K
YoY Change	0.0%	25.0%
% of Gross Profit	0.62%	0.82%
Operating Expenses	$61.27M	$59.10M
YoY Change	3.68%	15.4%
Operating Profit	$17.72M	$454.0K
YoY Change	3802.86%	-101.46%
Interest Expense	$11.28M	$15.24M
YoY Change	-26.01%	-6.42%
% of Operating Profit	63.64%	3356.83%
Other Income/Expense, Net
YoY Change
Pretax Income	$10.76M	-$12.36M
YoY Change	-187.09%	-72.78%
Income Tax	$200.0K	$100.0K
% Of Pretax Income	1.86%
Net Earnings	$10.56M	-$12.46M
YoY Change	-184.79%	-72.8%
Net Earnings / Revenue	2.34%	-3.07%
Basic Earnings Per Share	$0.13	-$0.16
Diluted Earnings Per Share	$0.12	-$0.16
COMMON SHARES
Basic Shares Outstanding	83.75M shares	79.40M shares
Diluted Shares Outstanding	93.95M shares	79.40M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$303.3M	$624.0M
YoY Change	-51.39%	105.13%
Cash & Equivalents	$306.5M	$625.6M
Short-Term Investments
Other Short-Term Assets	$31.50M	$6.300M
YoY Change	400.0%	12.5%
Inventory	$2.635B	$1.938B
Prepaid Expenses
Receivables	$87.40M	$65.60M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.057B	$2.634B
YoY Change	16.08%	23.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.571M	$7.887M
YoY Change	21.35%	1.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$70.00M	$123.2M
YoY Change	-43.19%	-4.64%
Other Assets	$42.10M	$65.80M
YoY Change	-36.02%	-12.62%
Total Long-Term Assets	$191.1M	$266.9M
YoY Change	-28.42%	-3.11%
TOTAL ASSETS
Total Short-Term Assets	$3.057B	$2.634B
Total Long-Term Assets	$191.1M	$266.9M
Total Assets	$3.248B	$2.901B
YoY Change	11.98%	20.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$138.2M	$108.3M
YoY Change	27.61%	33.87%
Accrued Expenses	$359.7M	$61.90M
YoY Change	481.1%	-81.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$362.1M	$170.2M
YoY Change	112.75%	-50.51%
LONG-TERM LIABILITIES
Long-Term Debt	$2.175B	$1.964B
YoY Change	10.76%	23.71%
Other Long-Term Liabilities	$26.40M	$291.3M
YoY Change	-90.94%
Total Long-Term Liabilities	$2.202B	$2.255B
YoY Change	-2.37%	42.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$362.1M	$170.2M
Total Long-Term Liabilities	$2.202B	$2.255B
Total Liabilities	$2.702B	$2.428B
YoY Change	11.3%	20.64%
SHAREHOLDERS EQUITY
Retained Earnings	$490.4M	$435.7M
YoY Change	12.53%
Common Stock	$906.0M	$898.5M
YoY Change	0.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$718.6M	$718.0M
YoY Change	0.08%
Treasury Stock Shares
Shareholders Equity	$546.3M	$473.1M
YoY Change
Total Liabilities & Shareholders Equity	$3.248B	$2.901B
YoY Change	11.98%	20.55%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$10.56M	-$12.46M
YoY Change	-184.79%	-72.8%
Depreciation, Depletion And Amortization	$500.0K	$500.0K
YoY Change	0.0%	25.0%
Cash From Operating Activities	-$221.1M	-$211.0M
YoY Change	4.75%	92.58%
INVESTING ACTIVITIES
Capital Expenditures	-$1.600M	-$400.0K
YoY Change	300.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$300.0K
YoY Change	-100.0%	-104.62%
Cash From Investing Activities	-$84.00K	-$734.0K
YoY Change	-88.56%	-112.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	-$4.926M	$311.6M
YoY Change	-101.58%	-4408.53%
NET CHANGE
Cash From Operating Activities	-$221.1M	-$211.0M
Cash From Investing Activities	-$84.00K	-$734.0K
Cash From Financing Activities	-$4.926M	$311.6M
Net Change In Cash	-$226.1M	$99.87M
YoY Change	-326.37%	-190.22%
FREE CASH FLOW
Cash From Operating Activities	-$221.1M	-$211.0M
Capital Expenditures	-$1.600M	-$400.0K
Free Cash Flow	-$219.5M	-$210.6M
YoY Change	4.19%	92.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	75749000	USD
CY2014Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	87355000	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	524298000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	504458000	USD
CY2014Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	138213000	USD
CY2013Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	148282000	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	99332000	USD
CY2014Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	87519000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	356176000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10600000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	386085000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17516000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17516000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	788893000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	790672000	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1779000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1013000	USD
CY2013Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	971000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1600000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5200000	shares
CY2014Q1	us-gaap	Assets Assets	3248172000	USD
CY2013Q4	us-gaap	Assets Assets	3193635000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306450000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	525688000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	532523000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	625558000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	99870000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-226073000	USD
CY2014Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	124200000	USD
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	436200000	USD
CY2013Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	68534000	USD
CY2014Q1	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	69443000	USD
CY2014Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12602735	shares
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0250
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0250
CY2014Q1	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	113911000	USD
CY2013Q4	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	113911000	USD
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	115296000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	115296000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12500000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
CY2013Q1	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	343265000	USD
CY2014Q1	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	369274000	USD
CY2014Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26103000	USD
CY2013Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	27366000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	859400000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	855000000	USD
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	467000	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	465000	USD
CY2014Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements</font><font style="font-family:inherit;font-size:10pt;">. In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force)” (“ASU 2013-11”), which states that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. ASU 2013-11 applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The amendments in ASU 2013-11 are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. We believe the adoption of this guidance will not have a material impact on our consolidated financial statements.</font></div></div>
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2094000	USD
CY2013Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2089000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2014Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2013Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1438000	USD
CY2014Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2013Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	187859000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	406032000	USD
CY2013Q1	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	0	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	3523000	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	165016000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	320646000	USD
CY2013Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	406032000	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	187859000	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	1465000	USD
CY2013Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-855000	USD
CY2013Q1	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	0	USD
CY2014Q1	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	6118000	USD
CY2014Q1	us-gaap	Investments In And Advances To Affiliates Amount Of Equity InvestmentsInAndAdvancesToAffiliatesAmountOfEquity	0	USD
CY2013Q4	us-gaap	Investments In And Advances To Affiliates Amount Of Equity InvestmentsInAndAdvancesToAffiliatesAmountOfEquity	0	USD
CY2014Q1	us-gaap	Financial Services Costs FinancialServicesCosts	852000	USD
CY2013Q1	us-gaap	Financial Services Costs FinancialServicesCosts	835000	USD
CY2014Q1	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	2350000	USD
CY2013Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	2593000	USD
CY2014Q1	us-gaap	Financial Services Revenue FinancialServicesRevenue	2420000	USD
CY2013Q1	us-gaap	Financial Services Revenue FinancialServicesRevenue	2403000	USD
CY2013Q1	us-gaap	Home Building Revenue HomeBuildingRevenue	402816000	USD
CY2014Q1	us-gaap	Home Building Revenue HomeBuildingRevenue	448267000	USD
CY2014Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2013Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	400000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	10763000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-12358000	USD
CY2014Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2584000	USD
CY2013Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	656000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	103000	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	120000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-326000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	10221000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14514000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2413000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	198761000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	205037000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3549000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	957000	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8402000	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1799000	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	1262000	USD
CY2013Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	1303000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	11276000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	15240000	USD
CY2013Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1000	USD
CY2014Q1	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
CY2014Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	667000	USD
CY2013Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2013Q1	us-gaap	Interest Paid Net InterestPaidNet	5872000	USD
CY2013Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	45562000	USD
CY2014Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	64971000	USD
CY2013Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	586439000	USD
CY2014Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	633396000	USD
CY2013Q4	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	645222000	USD
CY2014Q1	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	638208000	USD
CY2013Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	2298577000	USD
CY2014Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	2634944000	USD
CY2013Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1066916000	USD
CY2014Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1363340000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	204000	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	168000	USD
CY2013Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	130192000	USD
CY2014Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	60648000	USD
CY2014Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	41700000	USD
CY2013Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	41500000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3248172000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3193635000	USD
CY2014Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	200000000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	311636000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4926000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-734000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-221063000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-211032000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-12458000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	10563000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10536000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12458000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12458000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11205000	USD
CY2013Q1	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	27600000	USD
CY2014Q1	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	27010000	USD
CY2013Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2150498000	USD
CY2014Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2175190000	USD
CY2014Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	segment
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17719000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	454000	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	26383000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	25318000	USD
CY2013Q4	us-gaap	Other Assets OtherAssets	107076000	USD
CY2014Q1	us-gaap	Other Assets OtherAssets	110487000	USD
CY2013Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings ParticipatingSecuritiesDistributedAndUndistributedEarnings	0	USD
CY2013Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2089000	USD
CY2014Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings ParticipatingSecuritiesDistributedAndUndistributedEarnings	5000	USD
CY2013Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	430000	USD
CY2014Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1576000	USD
CY2014Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2013Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6878000	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2094000	USD
CY2013Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	304000	USD
CY2014Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	8618000	USD
CY2014Q1	us-gaap	Pledged Assets Not Separately Reported Real Estate PledgedAssetsNotSeparatelyReportedRealEstate	101600000	USD
CY2013Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2716000	USD
CY2014Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	5370000	USD
CY2014Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to the 2014 presentation. </font></div></div>
CY2014Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	20000	USD
CY2013Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	58000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	230000000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	52000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	109811000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	109811000	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-177000	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-2257000	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-2655000	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-17003000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	10110000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2013Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1674000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	0	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9571000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8460000	USD
CY2012Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	217684000	USD
CY2013Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	217161000	USD
CY2013Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	216681000	USD
CY2014Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	227200000	USD
CY2013Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	18705000	USD
CY2014Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	17485000	USD
CY2014Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	39280000	USD
CY2013Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	33422000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	41906000	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	42083000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	481889000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	490358000	USD
CY2014Q1	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	450000	USD
CY2013Q1	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	450000	USD
CY2014Q1	us-gaap	Revenues Revenues	450687000	USD
CY2013Q1	us-gaap	Revenues Revenues	405219000	USD
CY2013Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	91723000	USD
CY2013Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	92214000	USD
CY2012Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	93349000	USD
CY2014Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	90416000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61274000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59097000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1013000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1779000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9414988	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.24
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4947	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	48000000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10531938	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10526991	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.11
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.11
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	33.72
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	38000000	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y11M0D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M0D
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	48704000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	43419000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	47822000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	43333000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	8929000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	8711000	USD
CY2014Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3426000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2766000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6325000	shares
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2013Q1	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	6325000	shares
CY2013Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	52000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	109811000	USD
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	4000000	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	536086000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	546334000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	376806000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	473135000	USD
CY2013Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	8131000	USD
CY2014Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	6106000	USD
CY2013Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	18.25
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	718565000	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	718565000	USD
CY2014Q1	us-gaap	Undistributed Earnings Allocated To Participating Securities UndistributedEarningsAllocatedToParticipatingSecurities	22000	USD
CY2013Q1	us-gaap	Undistributed Earnings Allocated To Participating Securities UndistributedEarningsAllocatedToParticipatingSecurities	0	USD
CY2014Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	USD
CY2014Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	300000	USD
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates.</font></div></div>
CY2013Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	700000	USD
CY2014Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4400000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93946000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79401000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83745000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79401000	shares
CY2014Q1	kbh	Acquisition Costs Related To Land Option Contracts And Other Similar Contracts AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts	34700000	USD
CY2013Q4	kbh	Acquisition Costs Related To Land Option Contracts And Other Similar Contracts AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts	31000000	USD
CY2014Q1	kbh	Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges	284500000	USD
CY2013Q4	kbh	Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges	293100000	USD
CY2014Q1	kbh	Aggregate Purchase Price Associated With Land Option And Other Similar Contracts AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts	1090566000	USD
CY2013Q4	kbh	Aggregate Purchase Price Associated With Land Option And Other Similar Contracts AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts	1151496000	USD
CY2013Q4	kbh	Cash Deposits On Land Option And Other Similar Contracts CashDepositsOnLandOptionAndOtherSimilarContracts	41565000	USD
CY2014Q1	kbh	Cash Deposits On Land Option And Other Similar Contracts CashDepositsOnLandOptionAndOtherSimilarContracts	55634000	USD
CY2014Q1	kbh	Deposits Under Land Option And Other Similar Contracts DepositsUnderLandOptionAndOtherSimilarContracts	55700000	USD
CY2013Q4	kbh	Equity Method Investment Summarized Financial Information Accounts Payable And Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherLiabilities	85386000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Accounts Payable And Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherLiabilities	22843000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	17958000	USD
CY2013Q4	kbh	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	18752000	USD
CY2013Q4	kbh	Equity Method Investment Summarized Financial Information Inventories EquityMethodInvestmentSummarizedFinancialInformationInventories	381195000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Inventories EquityMethodInvestmentSummarizedFinancialInformationInventories	165133000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	149000	USD
CY2013Q4	kbh	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	1183000	USD
CY2013Q1	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-855000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-1130000	USD
CY2014Q1	kbh	Equity Method Investment Summarized Financial Information Receivable EquityMethodInvestmentSummarizedFinancialInformationReceivable	4619000	USD
CY2013Q4	kbh	Equity Method Investment Summarized Financial Information Receivable EquityMethodInvestmentSummarizedFinancialInformationReceivable	4902000	USD
CY2013Q1	kbh	Equityin Net Income Lossof Subsidiaries EquityinNetIncomeLossofSubsidiaries	0	USD
CY2014Q1	kbh	Equityin Net Income Lossof Subsidiaries EquityinNetIncomeLossofSubsidiaries	0	USD
CY2014Q1	kbh	Expected Realization Period Of Inventory ExpectedRealizationPeriodOfInventory	P5Y
CY2013Q1	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	1809000	USD
CY2014Q1	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	2616000	USD
CY2013Q1	kbh	Increase Decrease In Consolidated Inventories Not Owned IncreaseDecreaseInConsolidatedInventoriesNotOwned	4842000	USD
CY2014Q1	kbh	Increase Decrease In Consolidated Inventories Not Owned IncreaseDecreaseInConsolidatedInventoriesNotOwned	917000	USD
CY2014Q1	kbh	Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts	9800000	USD
CY2013Q4	kbh	Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts	8900000	USD
CY2013Q1	kbh	Increasein Inventories Dueto Distributionof Land From Equity Method Investments IncreaseinInventoriesDuetoDistributionofLandFromEquityMethodInvestments	0	USD
CY2013Q1	kbh	Intercompany Interest IntercompanyInterest	0	USD
CY2014Q1	kbh	Intercompany Interest IntercompanyInterest	0	USD
CY2014Q1	kbh	Intercompany Payables IntercompanyPayables	0	USD
CY2013Q4	kbh	Intercompany Payables IntercompanyPayables	0	USD
CY2014Q1	kbh	Intercompany Receivables IntercompanyReceivables	0	USD
CY2013Q4	kbh	Intercompany Receivables IntercompanyReceivables	0	USD
CY2014Q1	kbh	Intercompany Transactions IntercompanyTransactions	0	USD
CY2013Q1	kbh	Intercompany Transactions IntercompanyTransactions	0	USD
CY2014Q1	kbh	Interest Capitalized Net Of Amounts Paid InterestCapitalizedNetOfAmountsPaid	-8133000	USD
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	KB Home
CY2014Q1	kbh	Inventoryrelatedliabilities Inventoryrelatedliabilities	62748000	USD
CY2013Q4	kbh	Inventoryrelatedliabilities Inventoryrelatedliabilities	29517000	USD
CY2014Q1	kbh	Land Option Contract Abandonment Charges LandOptionContractAbandonmentCharges	433000	USD
CY2013Q1	kbh	Land Option Contract Abandonment Charges LandOptionContractAbandonmentCharges	0	USD
CY2014Q1	kbh	Land Option Contract Abandonment Lots LandOptionContractAbandonmentLots	650	lot
CY2014Q1	kbh	Land Option Contract Abandonment Lots Associatedwith Projects Less Than100000 LandOptionContractAbandonmentLotsAssociatedwithProjectsLessThan100000	3380	lot
CY2014Q1	kbh	Lineof Credit Facility Non Guarantor Subsidiary Threshold Percent LineofCreditFacilityNonGuarantorSubsidiaryThresholdPercent	0.10
CY2014Q1	kbh	Lineof Credit Facility Significant Subsidiary Threshold Percent LineofCreditFacilitySignificantSubsidiaryThresholdPercent	0.05
CY2013Q4	kbh	Long Lived Assets Heldand Used Carrying Value LongLivedAssetsHeldandUsedCarryingValue	1500000	USD
CY2014Q1	kbh	Maximum Warranty On Electrical Heating Cooling Plumbing And Other Building Systems MaximumWarrantyOnElectricalHeatingCoolingPlumbingAndOtherBuildingSystems	P5Y
CY2014Q1	kbh	Minimum Warranty On Electrical Heating Cooling Plumbing And Other Building Systems MinimumWarrantyOnElectricalHeatingCoolingPlumbingAndOtherBuildingSystems	P2Y
CY2014Q1	kbh	Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges	39	property
CY2013Q4	kbh	Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges	42	property
CY2014Q1	kbh	Number Of Investments In Unconsolidated Joint Ventures NumberOfInvestmentsInUnconsolidatedJointVentures	7	joint_venture
CY2013Q4	kbh	Number Of Investments In Unconsolidated Joint Ventures NumberOfInvestmentsInUnconsolidatedJointVentures	9	joint_venture
CY2013Q1	kbh	Number Of Land Parcels Or Communities Evaluated For Recoverability NumberOfLandParcelsOrCommunitiesEvaluatedForRecoverability	20	property
CY2014Q1	kbh	Number Of Land Parcels Or Communities Evaluated For Recoverability NumberOfLandParcelsOrCommunitiesEvaluatedForRecoverability	11	property
CY2014Q1	kbh	Numberof Unconsolidated Joint Venture Lots Controlled Under Land Option Contracts NumberofUnconsolidatedJointVentureLotsControlledUnderLandOptionContracts	673	lot
CY2013Q4	kbh	Numberof Unconsolidated Joint Venture Lots Controlled Under Land Option Contracts NumberofUnconsolidatedJointVentureLotsControlledUnderLandOptionContracts	5367	lot
CY2014Q1	kbh	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Or Other Similar Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionOrOtherSimilarContracts	100000	USD
CY2013Q4	kbh	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Or Other Similar Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionOrOtherSimilarContracts	100000	USD
CY2014Q1	kbh	Ownership Share In Guarantor Subsidiaries OwnershipShareInGuarantorSubsidiaries	1
CY2013Q1	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-3435000	USD
CY2014Q1	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-4414000	USD
CY2014Q1	kbh	Paymentsfor Proceedsfrom Intercompany Transactions Investing Activities PaymentsforProceedsfromIntercompanyTransactionsInvestingActivities	0	USD
CY2013Q1	kbh	Paymentsfor Proceedsfrom Intercompany Transactions Investing Activities PaymentsforProceedsfromIntercompanyTransactionsInvestingActivities	0	USD
CY2013Q4	kbh	Performance Bonds PerformanceBonds	410800000	USD
CY2014Q1	kbh	Performance Bonds PerformanceBonds	427000000	USD
CY2014Q1	kbh	Remaining Useful Life Maximum RemainingUsefulLifeMaximum	P10Y
CY2014Q1	kbh	Remaining Useful Life Minimum RemainingUsefulLifeMinimum	P1Y
CY2013Q4	kbh	Self Insuranceand Other Litigation Liabilities SelfInsuranceandOtherLitigationLiabilities	99612000	USD
CY2014Q1	kbh	Self Insuranceand Other Litigation Liabilities SelfInsuranceandOtherLitigationLiabilities	94939000	USD
CY2014Q1	kbh	Structural Warranty Provided By Company StructuralWarrantyProvidedByCompany	P10Y
CY2013Q1	kbh	Title Services TitleServices	649000	USD
CY2014Q1	kbh	Title Services TitleServices	708000	USD
CY2014Q1	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	20000	USD
CY2013Q1	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	0	USD
CY2014Q1	kbh	Warranty For Other Components Of Home WarrantyForOtherComponentsOfHome	P1Y
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-02-28
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000795266
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	83744528	shares
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer

Files In Submission

Name	View Source	Status
0000795266-14-000025-index-headers.html	Edgar Link	pending
0000795266-14-000025-index.html	Edgar Link	pending
0000795266-14-000025.txt	Edgar Link	pending
0000795266-14-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kbh-02282014x10q.htm	Edgar Link	pending
kbh-02282014xexhibitx1048.htm	Edgar Link	pending
kbh-02282014xexhibitx311.htm	Edgar Link	pending
kbh-02282014xexhibitx312.htm	Edgar Link	pending
kbh-02282014xexhibitx321.htm	Edgar Link	pending
kbh-02282014xexhibitx322.htm	Edgar Link	pending
kbh-20140228.xml	Edgar Link	completed
kbh-20140228.xsd	Edgar Link	pending
kbh-20140228_cal.xml	Edgar Link	unprocessable
kbh-20140228_def.xml	Edgar Link	unprocessable
kbh-20140228_lab.xml	Edgar Link	unprocessable
kbh-20140228_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KBH
KB HOME Stock $kbh

2014 Q1 Form 10-Q Financial Statement

#000079526614000025 Filed on April 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBH KB HOME Stock $kbh

2014 Q1 Form 10-Q Financial Statement

#000079526614000025 Filed on April 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBH
KB HOME Stock $kbh